Boston Scientific Global HR Change Enablement Specialist 

United States, Massachusetts, Marlborough 

360900356

US-MA-Marlborough; Ireland-Cork; Ireland-Galway; US-CA-Valencia; US-MN-Arden Hills

Your responsibilities will include:

• Support the development and implementation of an effective Change Enablement Strategy to accelerate the adoption of the model and enabling technologies
• Partner with Change Enablement Lead and cross-functional global teams to evaluate change needs to support various personas throughout the change cycle
• Understand change needs and develop creative content and consistent messaging to support aligned with Boston Scientific values and brand standards
• Stay abreast of HR work across the model and help connect efforts to identify synergies and gaps to accelerate change and manage risk
• Regularly evaluate the effectiveness of change activities and communications to ensure alignment and progression of strategy and goals

Required Qualifications:

• Bachelor’s degree or the equivalent combination of education and experience required
• 2+ years’ relevant experience
• Excellent written and verbal communication skills

Preferred Qualifications:

• Project Management and/or Communications background preferred
• Experience creating content for print and digital platforms preferred

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.